Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Breast CancerGenitourinary CancerLung CancerMelanomaMixed TopicsBusiness of MedicineAML
Meat Linked to Higher Erectile Dysfunction RiskApril 16, 2024OncologyGenitourinary CancerProstate Cancer
No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024MelanomaLung CancerGenitourinary CancerBreast CancerOncologyAMLBusiness of Medicine
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024Breast CancerGenitourinary CancerMelanomaLung CancerMixed TopicsMultiple MyelomaMyelodysplastic Syndrome
Repeat MCED Testing May ID Early-Stage and Unscreened CancersApril 10, 2024Breast CancerGenitourinary CancerLung CancerMelanomaOncologyProstate Cancer
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Breast CancerGenitourinary CancerMelanomaMixed TopicsAMLMultiple MyelomaOncology
New Trials in Prostate Cancer: Could Your Patient Benefit?April 8, 2024Genitourinary CancerProstate Cancer
Virtual Reality Brings Relief to Hospitalized Patients With CancerApril 8, 2024OncologyPainBreast CancerGenitourinary CancerLung CancerMelanomaAML
Prostate Cancer Tsunami Coming, Experts CautionApril 5, 2024Genitourinary CancerDiversity in MedicineOncologyBusiness of MedicineProstate Cancer
A Banned Chemical That Is Still Causing CancerApril 3, 2024Breast CancerGenitourinary CancerLung CancerMelanomaMixed TopicsOncologyBusiness of Medicine
Active Surveillance for Cancer Doesn’t Increase Malpractice RiskApril 1, 2024Genitourinary CancerBreast CancerLung CancerMelanomaAMLBusiness of MedicineMixed Topics
Women’s Cancers: Clinicians Research, Advise on Sexual DysfunctionMarch 29, 2024Genitourinary CancerBreast CancerSexual HealthWomen's HealthPainOncology
VA to Expand Cancer Prevention ServicesMarch 25, 2024CancerOncologyLung CancerColon and RectalGenitourinary Cancer
New Guidelines: Start PSA Screening Earlier in Black MenMarch 22, 2024Genitourinary CancerOncologyProstate Cancer
